Construction of an intervention program for peripheral neurotoxicity symptoms in breast cancer chemotherapy patients and design of a home care system

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500101548

Enrollment

Unknown

Registered

2025-04-25

Start date

2025-04-28

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Observation group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 Age >= 18 years old; 2 Breast cancer diagnosed by pathological examination; patients treated with chemotherapy (including neoadjuvant and postoperative adjuvant chemotherapy); 3 Informed consent and able to communicate and answer questions normally; 4 Completion of at least one chemotherapy cycle

Exclusion criteria

Exclusion criteria: 1 Patients with other cancers or serious life-threatening diseases; 2 Patients with audio-visual disorders, or previous mental and cognitive disorders; 3 Patients with other peripheral neuropathy diseases before chemotherapy

Design outcomes

Primary

Measure	Time frame
None;	—

Countries

China

Contacts

Public ContactGuo Xinrong

The Second Norman Bethune Hospital of Jilin University

guoxr@jlu.edu.cn+86 155 2689 1949

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026